The chemical class known as PDZK11 Activators encompasses a group of diverse compounds that engage cellular signaling pathways, which can lead to the modulation of the activity of the protein PDZK11. PDZK11 is a PDZ domain-containing protein, and proteins within this family typically play crucial roles in maintaining cellular organization, facilitating signal transduction, and ensuring proper receptor localization. The activators in this class interact with various components of cellular signaling cascades, from surface receptors to secondary messengers and kinases, which in turn can influence the function of PDZK11. The interactions can lead to changes in the phosphorylation patterns of proteins, alter protein-protein interactions, and modify the localization and stability of PDZK11 within the cell.
To identify activators within this class, researchers employ a series of methodological approaches. Initial steps often involve high-throughput screening, where vast libraries of compounds are tested for their ability to affect PDZK11 or the signaling pathways it is part of. Subsequent in vitro assays are conducted to confirm the activity of these compounds, which may include binding assays to determine direct interactions with PDZK11 or its partners. Advances in structural biology can also provide insights into how these activators bind at the molecular level, offering a more detailed understanding of the activation mechanism. Once identified, the activators are subjected to further characterization to unravel their specific effects on PDZK11's activity. These studies are complemented by cell-based assays to observe the consequences of activator-induced modulation of PDZK11 in a more complex biological context, such as changes in cellular localization, interaction with other proteins, and downstream signaling events. Through these comprehensive analyses, a clearer picture of the role of PDZK11 activators within the cell emerges, contributing to the broader understanding of cellular signaling dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cAMP levels in cells, potentially leading to changes in PKA activity that could possibly activate PDZK11 by altering its phosphorylation state or the phosphorylation state of associated proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which could possibly activate PDZK11 by phosphorylating proteins that interact with PDZ domains, potentially altering PDZK11 function or localization. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, which could possibly activate PDZK11 by activating calcium-dependent signaling pathways that interact with PDZ domain-containing proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β within the Wnt signaling pathway, potentially leading to changes that could possibly activate PDZK11, as PDZ proteins can be part of complexes regulated by Wnt. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, potentially leading to increased phosphorylation levels within the cell that could possibly activate PDZK11 by affecting its interactions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, potentially affecting the AKT signaling pathway and leading to changes that could possibly activate PDZK11, considering the role of PDZ domain proteins in cell survival and proliferation signals. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially leading to changes that could possibly activate PDZK11, as PDZ domain proteins might be involved in stress response pathways regulated by p38 MAPK. | ||||||